MURINE SURVIVAL OF LETHAL IRRADIATION WITH THE USE OF HUMAN UMBILICAL-CORD BLOOD

被引:10
作者
ENDE, N
PONZIO, NM
ATHWAL, RS
ENDE, M
GIULIANI, DC
机构
[1] SOUTHSIDE REG MED CTR,DEPT LAB MED & PATHOL,PETERSBURG,VA
[2] SOUTHSIDE REG MED CTR,DIV MED HEMATOL,PETERSBURG,VA
[3] SOUTHSIDE REG MED CTR,DEPT MICROBIOL & MOLEC GENET,PETERSBURG,VA
关键词
D O I
10.1016/0024-3205(92)90013-F
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have found that human umbilical cord blood (HUCB) will routinely protect mice exposed to lethal levels of irradiation. At the end of 50 days, over seventy percent (70%) of mice injected with HUCB survived 900 cGy or irradiation, which produced 100% deaths in the uninjected control animals. Moreover, there was some evidence that human colony stimulating factors further improved survival. Anti-Natural Killer cell (NK) antibody was utilized along with HUCB in these studies, however, Anti-NK cell serum alone had no radioprotective effect in mice. The studies reported here suggest the possibility of utilizing HUCB for immediate protection of humans from lethal irradiation.
引用
收藏
页码:1249 / 1253
页数:5
相关论文
共 10 条
[1]  
AFIFI MS, 1985, J IMMUNOL, V134, P3739
[2]   BONE-MARROW TRANSPLANTATION AFTER THE CHERNOBYL NUCLEAR ACCIDENT [J].
BARANOV, A ;
GALE, RP ;
GUSKOVA, A ;
PIATKIN, E ;
SELIDOVKIN, G ;
MURAVYOVA, L ;
CHAMPLIN, RE ;
DANILOVA, N ;
YEVSEEVA, L ;
PETROSYAN, L ;
PUSHKAREVA, S ;
KONCHALOVSKY, M ;
GORDEEVA, A ;
PROTASOVA, T ;
REISNER, Y ;
MICKEY, MR ;
TERASAKI, PI .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (04) :205-212
[3]  
Ende M, 1972, Va Med Mon (1918), V99, P276
[4]  
Ende N, 1990, Va Med Q, V117, P282
[5]  
ENDE N, 1990, LIFE SCI, V6, P1373
[6]  
LINNEMANN RE, 1987, JAMA-J AM MED ASSOC, V258, P637
[7]  
MURPHY EDWIN D., 1963, PROC AMER ASSOC CANCER RES, V4, P46
[8]  
Pegg D. E., 1966, BONE MARROW TRANSPLA
[9]  
Ponzio N M, 1986, Int Rev Immunol, V1, P273, DOI 10.3109/08830188609056610
[10]  
TIBERGHIEN P, 1990, BLOOD, V76, P1419